icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
Safety and Efficacy of Vesatolimod (GS-9620) in Patients With Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment
 
 
    Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
 
Kosh Agarwal,1 Sang Hoon Ahn,2 Magdy Elkhashab,3 Kyungpil Kim,4 Audrey H. Lau,4 Anuj Gaggar,4 G. Mani Subramanian,4
John G. McHutchison,4 Pietro Andreone,5 Hyung Joon Kim,6 Wan-Long Chuang,7 Mindie H. Nguyen8
1Institute of Liver Studies, King's College Hospital, London, UK; 2Severance Hospital, Yonsei University Health System, Seoul, South Korea; 3Toronto Liver Centre, Toronto, Ontario, Canada; 4Gilead Sciences, Inc., Foster City, CA; 5Azienda Ospedaliero-Universitaria di Bologna, Italy; 6Chung-Ang University Hospital, Seoul; 7Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; 8Stanford University, Palo Alto, CA

1108171

1108172

1108173

1108174

1108175

1108176

1108177

1108178

1108179